Publications by authors named "Xilin Du"

Claim this Profile
T
The Effects of CD100 Stimulation on Primary Human Hepatocytes (PHHs) and Its Implications in HBV-Related Liver Cirrhosis.
Chao Fan, Xiaojun He, Yun Zhou, Chuantao Ye, Xuyang Zheng, Xilin Du

J Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIPS improves survival in patients with cirrhosis and recurrent ascites: a multicenter observational study.
Bo Wang, Jun Zhu, Jing Li, Shoujie Zhao, Yejing Zhu, Xilin Du

Int J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver resection versus interventional treatments for hepatocellular carcinoma patients with hypohepatia: a multicenter study.
Shoujie Zhao, Yejing Zhu, Jinming Zhu, Bo Wang, Enxin Wang, Xilin Du

Surg Endosc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial.
Jian Zhou, Li Bai, Jia Luo, Yuxian Bai, Yaozhen Pan, Xilin Du

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
Haowen Tang, Wenwen Zhang, Junning Cao, Yinbiao Cao, Xinyu Bi, Shunda Du, Binwei Duan, Feng Duan, Xilin Du

Biosci Trends· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A description of the correction of data error and the direction of in-depth research.
Jian Xiong, Weiling Yin, Xilin Du, Zhonghua Luo

J Gastrointest Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of positive cofactor 4 as a diagnostic and prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
Liangliang Bai, Guan Liu, Gang Dou, Xiaojun He, Chenyu Gong, Xilin Du

ILIVER· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Tislelizumab, Lenvatinib, and FOLFOX4-HAIC as a Conversion Therapy for Unresectable Hepatocellular Carcinoma.
Kai Tan, Xiaojun He, Haoran Yuan, Shoujie Zhao, Chenyu Gong, Xilin Du

ILIVER· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different methods of vaginal preparation before cesarean delivery to prevent postoperative infection: a systematic review and network meta-analysis.
Guan Liu, Jia Liang, Liangliang Bai, Gang Dou, Kai Tan, Xilin Du

Am J Obstet Gynecol MFM· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study.
Jian Xiong, Yanyan Zhou, Kai Tan, Haofeng Liu, Yunbao Cao, Xilin Du

J Gastrointest Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling.
Shixiong Lei, Xilin Du, Kai Tan, Xiaojun He, Yejing Zhu

Exp Ther Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study.
Tingting Bai, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Xilin Du

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study.
Yejing Zhu, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Xilin Du

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying optimal therapies in patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis.
Zhenyu Yang, Yao Tong, Lin Yang, Xianli He, Guoqiang Bao, Xilin Du

Transl Gastroenterol Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1" [Gene 670 (2018) 114-122].
Tao Yang, Xiaojun He, An Chen, Kai Tan, Xilin Du

Gene· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
Shoujie Zhao, Xiangnan Zhang, Mengmeng Wang, Kai Tan, Weijia Dou, Xilin Du

Ann Transl Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Shoujie Zhao, Min Long, Xiangnan Zhang, Shixiong Lei, Weijia Dou, Xilin Du

Ann Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
Shoujie Zhao, Ting Zhang, Huichen Li, Mengmeng Wang, Ke Xu, Xilin Du

Ann Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.
Shoujie Zhao, Mengmeng Wang, Zhenyu Yang, Kai Tan, Desha Zheng, Xilin Du

Ann Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis.
Shoujie Zhao, Ting Zhang, Weijia Dou, Enxin Wang, Mengmeng Wang, Xilin Du

Ann Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-139 suppresses hepatocellular carcinoma cell proliferation and migration by directly targeting Topoisomerase I.
Pengfei Zhang, Jikai Yin, Lijuan Yuan, Qing Wang, Xilin Du

Oncol Lett· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RETRACTED: LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1.
Tao Yang, Xiaojun He, An Chen, Kai Tan, Xilin Du

Gene· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of let-7f-5p promotes chemotherapeutic resistance in colorectal cancer by directly repressing several pro-apoptotic proteins.
Yateng Tie, Chong Chen, Yanli Yang, Zhen Qian, Hang Yuan, Xilin Du

Oncol Lett· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic compression anastomosis for enteroenterostomy under peritonitis conditions in dogs.
Hongke Zhang, Kai Tan, Chao Fan, Jingwei Du, Jiangbin Li, Xilin Du

J Surg Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
Shixiong Lei, Jiandong Yang, Chong Chen, Jiachen Sun, Liu Yang, Xilin Du

J Exp Clin Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis